NCT00453713

Race, Ethnicity, and Diffuse Parenchymal Lung Disease

Determinants of Outcome in Diffuse Parenchymal Lung Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 565 (actual)
• Sponsor: Columbia University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.

Detailed description

It is well known that both socioeconomic and biological factors may contribute to race- and ethnicity-based health disparities. Black and Hispanic Americans have worse access to healthcare services and tend to receive care from physicians who cannot themselves access the same services for their patients that physicians who care for white patients can. These factors may play important roles in the development and maintenance of health disparities. In addition, biological differences may contribute to disparities. We propose to identify factors that explain survival disparities in a group of lung diseases called diffuse parenchymal lung diseases (DPLDs), including a severe form of DPLD called idiopathic pulmonary fibrosis (IPF). We will follow patients with DPLD at our center and measure both social and biological factors to try to identify the factors that lead to survival disparities between races. Results of this study will be used to design clinical trials aimed at reducing these disparities.

Conditions

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Diffuse Parenchymal Lung Disease

Timeline

• Start date: 2006-07-01
• Primary completion: 2013-08-01
• Completion: 2013-08-01
• First posted: 2007-03-29
• Last updated: 2015-04-21

Locations

1 site across 1 country: United States